WithdrawnNANCT04462250

Development of a Mobile Health App to Improve the Safe Use, Storage, and Disposal of Opioid Medications

Sponsor: Rutgers, The State University of New Jersey

Trial Details

Condition	Opioid Use
Intervention	Prescription Opioid Management App
Phase	NA
Status	Withdrawn
Est. Completion	28 Feb 2021
Last Updated	16 Apr 2026

Primary Outcome

Device functionality

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Has current prescription for opioid medication * Any ethnic group * Served through the following programs of partnering organization: primary medical care, transgender medical care, HIV and sexually transmitted infection (STI) screening and counseling, LGBTQ services, pre-exposure prophylaxis and post exposure prophylaxis services, health education, clinical research, case management, psychosocial services, nutrition counseling, treatment adherence * Owns an Android-base smartphone Exclusion Criteria: * Unable to provide informed consent * Pregnant women * Currently being treated for/history of mental health or substance use disorder

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Withdrawn Mobile Health Trial Highlights Critical Gap in Opioid Safety Technology — Lessons for Australian Digital Health

A withdrawn US feasibility study aimed to develop a mobile app for safer opioid use among vulnerable populations. Despite its withdrawal, the research highlights critical gaps in digital health solutions for medication safety that remain relevant for Australian healthcare systems.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service